What is the cut-off titer for Antistreptolysin O (ASO)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

ASO Titer Cut-off Values

The upper limit of normal for ASO titer is approximately 200-250 IU/mL in children and adolescents, though this varies by geographic location, age, and local streptococcal prevalence patterns. 1, 2

Standard Cut-off Values by Population

  • Children (5-15 years): The upper limit of normal is 239 IU based on studies of healthy children with no recent streptococcal infection 2
  • General pediatric population: Values of 333 units or more should be considered abnormal, as 15-20% of healthy children may have titers between 250-333 units 3
  • Adults: Generally lower than children, with most laboratories using 200 IU as the upper limit of normal 4

Critical Interpretation Considerations

ASO titers must be interpreted in clinical context, not as standalone diagnostic criteria. 1, 4

  • ASO begins rising approximately 1 week after streptococcal infection and peaks between 3-6 weeks, with sensitivity of 80-90% for detecting prior infection 1
  • Titers can remain elevated for several months after uncomplicated infections, making timing crucial for interpretation 1
  • Anti-DNase B testing should be performed concurrently, as it has higher sensitivity (90-95%) and rises 1-2 weeks after infection, peaking at 6-8 weeks 1

Geographic and Temporal Variability

The normal upper limit varies significantly by geographic location and can change annually within the same population. 3

  • Annual variations can show up to six-dilution differences in normal upper limits between different years in the same population 3
  • Local streptococcal prevalence patterns directly influence population baseline titers 3, 2
  • Physicians must consider local epidemiological data when interpreting results 3

Clinical Application for Post-Streptococcal Complications

ASO testing is indicated only for confirming previous streptococcal infection in suspected post-streptococcal complications (acute rheumatic fever, post-streptococcal glomerulonephritis), NOT for diagnosing acute pharyngitis. 1

When to Order ASO Testing:

  • Acute rheumatic fever: Patients with migratory arthritis, carditis, chorea, erythema marginatum, or subcutaneous nodules 1
  • Post-streptococcal glomerulonephritis: Patients with hematuria, proteinuria, edema, and hypertension 1
  • Never for: Routine pharyngitis evaluation or as sole indication for tonsillectomy 1, 5

Common Pitfalls to Avoid

  • Elevated ASO does not correlate with ESR, CRP, or rheumatoid factor and can be found in various non-streptococcal conditions 4
  • Only 14% of patients with elevated ASO have positive streptococcal cultures, so elevated titer alone does not confirm active infection 4
  • Specificity is only 12% when using ASO alone without confirming Group A beta-hemolytic streptococci in tissue culture 5
  • Performing tonsillectomy based solely on elevated ASO without documented GABHS in tonsillar tissue is not evidence-based 5

References

Guideline

Diagnosis and Treatment of Post-Streptococcal Complications

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Annual changes of upper limit of ASO titer in school children.

Japanese circulation journal, 1983

Research

Evaluation of the validity of high serum antistreptolysin o titre only, as an indication for tonsillectomy.

Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India, 2014

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.